Statistics for Survival outcomes with 12 weeks of adjuvant or neoadjuvant trastuzumab in breast cancer

Total visits

views
Survival outcomes with 12 weeks of adjuvant or neoadjuvant trastuzumab in breast cancer 0

Total visits per month

views
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0

File Visits

views
IJC2022v59n3p387.pdf 2